Iron(III)-hydroxide polymaltose complex is a medication used to treat iron deficiency / iron deficiency anemia and belongs to the group of oral iron preparations. The preparation is a macromolecular complex, consisting of iron(III)-hydroxide (trivalent iron, Fe3+) and the carrier polymaltose and is available in solid form as a film coated or chewable tablet and in liquid form as a syrup, drinkable solution, or drops. It is used for treating iron deficiency without anemia (latent iron deficiency) or with anemia (apparent iron deficiency). Prior to administration the iron deficiency should be diagnostically established and verified via laboratory tests (e.g low ferritin concentration low transferrin saturation).
Technical Specification
Name | Iron Polymaltose Complex |
Therapeutic Category | Antianemic Agent |
Chemical Name | iron(3+);(2R,3S,4R,5R)-2,3,4,5-tetrahydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal;trihydroxide |
Category | Api Products |
LIVEALTH BIOPHARMA PVT. LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |